Houston Methodist DeBakey Heart and Vascular Center
Avatar

Lipid Lowering Drugs for PAD: How Efficient Are Statins and PCSK9 Inhibitors for Preventing Cardiovascular Events Based on the REACH Registry and FOURIER Trial?

By Houston Methodist DeBakey Heart and Vascular Center FEATURING Mark Creager
By Houston Methodist DeBakey Heart and Vascular Center FEATURING Mark Creager
480 views
March 24, 2021
0 Comments
Login to view comments. Click here to Login

Featured Video

11:49
Shockwave IVL

Size for Success Part 1: Why We Undersize our Endovascular Tools &am…

Feat. E. Secemsky, M. Siah

Featured Video

18:06
Lilly Obesity

Getting Patients Started with an Obesity Treatment Option for Adults

Feat. E. Lazarus

Related Content

AUTOPLAY
12:04
Stephen Kopecky

Role of PCSK9 Inhibitors in Diabetes

28:13
National Lipid Association

New Insights into Triglyceride Therapy and the Role of Omega-3 Fatty…

Feat. R. Mason
59:01
The North American Thrombosis Forum (NATF)

Recent Cholesterol Guidelines and Integration into Clinical Practice

Feat. J. Plutzky, L. Braun, J. Ross
18:43
Canadian Collaborative Research Network

Lp(a): When to Measure it and What to Do About it

Feat. M. O'Donoghue
08:44
AHA 2022 Conference Coverage

AHA 2022: Cardiovascular Benefit of Lowering LDL Cholesterol Below 4…

Feat. N. Marston
21:27
Scripps Health

Lipids Update: Current Guidelines for Lipid Management

Feat. S. R. Mehta
14:50
AHA 2022 Conference Coverage

AHA 2022: Long-Term Efficacy and Safety of Inclisiran in Patients Wi…

Feat. K. Ray
19:09
ACC 2023 Conference Coverage

ACC 2023: Management of Statin Side Effects and How to Keep Them on …

Feat. J. Saseen
34:20
Cedars Sinai

Cardiology’s Biggest Controversy: The Lumen or the Wall - the Curiou…

Feat. J. Forrester
19:16
The Texas Heart Institute

Role of Coronary Calcification and Risk Stratification

Feat. E. Hernandez
45:45
Houston Methodist DeBakey Heart and Vascular Center

Directions of Cardiology in the Next Decade: 2022-2032

Feat. E. Braunwald
31:02
Scripps Health

How Do I Reverse Coronary Plaque?

Feat. C. J. Suhar
24:02
Complex Coronary Cases

Updated Lipid Guidelines and Therapy

Feat. I. Fergus
19:48
ACC 2022 Conference Coverage

ACC 2022: Updates on Lowering LDL-C in Secondary Prevention - "…

Feat. R. Giugliano
39:44
The Texas Heart Institute

Lipid Lowering Therapies: Where Did We Start, Where We Are Now and W…

Feat. S. Virani
08:50
The Texas Heart Institute

Inside the Studio with Drs. Joseph Rogers and Salim Virani - Current…

Feat. J. Rogers, S. Virani
42:25
Piedmont Heart Institute

Peripheral Arterial Disease: How To Prevent? When To Diagnose? How T…

Feat. A. Klein
31:27
Scripps Health

Evaluate the Horrible Cholesterol Lp(a): Prevalence, Impact and Nove…

Feat. N. Lepor
24:10
ACC 2022 Conference Coverage

ACC 2022: How I Manage Statin-associated Muscle Symptoms and Other B…

Feat. P. Toth
33:43
Jefferson Health

Update on Lipids: Current Options for Lowering LDL to Reduce CV Risk

Feat. A. Cohen